Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

NCT00783146 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

728

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: desloratadine
DRUG: fexofenadine
DRUG: placebo

Sponsor

Organon and Co